Previous 10 | Next 10 |
2023-08-08 16:37:21 ET Amphastar Pharmaceuticals press release ( NASDAQ: AMPH ): Q2 Non-GAAP EPS of $0.65 beats by $0.09 . Revenue of $145.7M (+18.0% Y/Y) beats by $8.73M . Cash flow provided by operating activities for the six months ended June 30, 2023 was $9...
Reports Net Revenues of $145.7 Million for the Three Months Ended June 30, 2023 RANCHO CUCAMONGA, CA / ACCESSWIRE / August 8, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended June 30, 2023. Second Quarter...
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 2, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2023 ended June 30, 2023, after the market closes on Tuesday, August 8, 2023, and will hold a conference call to discuss it...
2023-07-28 17:42:33 ET Summary Amphastar Pharmaceuticals specializes in complex generics and proprietary injectable products, expanding its range with FDA-approved additions. With projections of steady financial growth, Amphastar's stock outperforms the S&P 500, despite a high...
2023-07-12 06:13:33 ET Summary Amphastar Pharmaceuticals' share price has risen 54% in the last 12 months, outperforming the healthcare sector, due to its diversified revenues and recent acquisition of BAQSIMI from Eli Lilly and Company. The company's net margins have improved sig...
RANCHO CUCAMONGA, CA / ACCESSWIRE / June 30, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today announced that it has completed the previously announced acquisition of BAQSIMI ® from Eli Lilly and Company ("Lilly") (the "Acquisition"). Acquisition H...
Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) traded at a new 52-week high today and are currently trading at $55.32. So far today, approximately 594.43k shares have been exchanged, as compared to an average 30-day volume of 412.19k shares. Amphastar Pharmaceuticals, Inc., a bio-ph...
2023-05-13 14:13:10 ET Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2023 Results Conference Call May 09, 2023 5:00 PM ET Company Participants Dan Dischner - VP of HR & Corporate Communication William Peters - CFO, Executive VP of Finance, Treasurer & Director ...
2023-05-09 16:56:47 ET Amphastar Pharmaceuticals press release ( NASDAQ: AMPH ): Q1 Non-GAAP EPS of $0.62 beats by $0.13 . Revenue of $140M (+16.3% Y/Y) beats by $4.37M . For further details see: Amphastar Pharmaceuticals Non-GAAP EPS of $0.62 beats by $0...
Reports Net Revenues of $140.0 Million for the Three Months Ended March 31, 2023 RANCHO CUCAMONGA, CA / ACCESSWIRE / May 9, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended March 31, 2023. First Quarter Hi...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...